Solid forms comprising 4- [9- (tetrahydro-furan-3-yl) -8- (2,4,6-trifluoro-phenylamino) -9H-purin-2-ylamino] -cyclohexan-1-ol, its compositions and its uses
A crystalline form comprising 4 - ((9 - ((3S) -tetrahydro-furan-3-yl) -8 - ((2,4,6-trifluoro-phenyl) -amino) -9H-purin-2-yl ) amino) -trans-cyclohexanol, where the crystalline form has an X-ray powder diffraction pattern comprising peaks at 12.4 ± 0.1, 16.0 ± 0.1 and 18.5 ± 0.1 ° 2θ